Evidence map›Paper›PMID 40455800›Full record

ArticleBiostatistics (Oxford, England)2025

Sensitivity analysis for the probability of benefit in randomized controlled trials with a binary treatment and a binary outcome.

Iuliana Ciocănea-Teodorescu, Erin E Gabriel, Arvid Sjölander

Abstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Iuliana Ciocănea-TeodorescuVictor Babeş National Institute of Pathology, Splaiul Independenţei 99-101, Bucharest 050096, Romania.ORCID 0000-0003-2489-9025
Erin E GabrielSection of Biostatistics, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, Copenhagen DK-1353, Denmark.ORCID 0000-0002-0504-8404
Arvid SjölanderDepartment of Medical Epidmiology and Biostatistics, Karolinska Institute, Stockholm 171 77, Sweden.ORCID 0000-0001-5226-6685

Funding

Novo Nordisk Foundation NNF22OC0076595Romanian Ministry of Research, Innovation and Digitization PN 23.16.01.01Swedish Research Council 2016-01267
6 · The paper itself

Abstract

For a comprehensive understanding of the effect of a given treatment on an outcome of interest, quantification of individual treatment heterogeneity is essential, alongside estimation of the average causal effect. However, even in randomized controlled trials, quantities such as the probability of benefit or the probability of harm are not identifiable, since multiple potential outcomes cannot be observed simultaneously for the same individual. We propose a sensitivity analysis for the probability of benefit in randomized controlled trial settings with a binary treatment and a binary outcome, by quantifying the deviation from conditional independence of the two potential outcomes, given a set of measured prognostic baseline covariates. We do this using a marginal sensitivity analysis parameter that does not depend on the number or complexity of the measured covariates. We provide a guide to estimation and interpretation, and illustrate our method in simulations, as well as using a real data example from a randomized controlled trial studying the effect of umbilical vein oxytocin administration on the need for manual removal of the placenta during birth.

Indexed as

Models, StatisticalRandomized Controlled Trials as TopicComputer SimulationData Interpretation, StatisticalFemaleHumansPregnancyProbabilityTreatment Outcomeprobability of benefitrandomized controlled trialsensitivity analysis

Identifiers

PMID40455800
PMCPMC12129078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.